BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11398879)

  • 1. FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT.
    Franzius C; Daldrup-Link HE; Sciuk J; Rummeny EJ; Bielack S; Jürgens H; Schober O
    Ann Oncol; 2001 Apr; 12(4):479-86. PubMed ID: 11398879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy.
    Franzius C; Sciuk J; Daldrup-Link HE; Jürgens H; Schober O
    Eur J Nucl Med; 2000 Sep; 27(9):1305-11. PubMed ID: 11007511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma.
    Hurley C; McCarville MB; Shulkin BL; Mao S; Wu J; Navid F; Daw NC; Pappo AS; Bishop MW
    Pediatr Blood Cancer; 2016 Aug; 63(8):1381-6. PubMed ID: 27082077
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Bosma SE; Vriens D; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Bloem JL
    Skeletal Radiol; 2019 Nov; 48(11):1735-1746. PubMed ID: 31016339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of 18F-FDG PET/CT in the metabolic characterization of lung nodules in pediatric patients with bone sarcoma.
    Cistaro A; Lopci E; Gastaldo L; Fania P; Brach Del Prever A; Fagioli F
    Pediatr Blood Cancer; 2012 Dec; 59(7):1206-10. PubMed ID: 22745027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is methylene diphosphonate bone scan necessary for initial staging of Ewing sarcoma if 18F-FDG PET/CT is performed?
    Ulaner GA; Magnan H; Healey JH; Weber WA; Meyers PA
    AJR Am J Roentgenol; 2014 Apr; 202(4):859-67. PubMed ID: 24660717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of [F-18]-fluorodeoxy-D-glucose positron emission tomography, bone scan, and bone marrow aspiration/biopsy as staging investigations in Ewing sarcoma.
    Newman EN; Jones RL; Hawkins DS
    Pediatr Blood Cancer; 2013 Jul; 60(7):1113-7. PubMed ID: 23192939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Accuracy of 18F-FDG PET/CT in the Staging and Assessment of Response to Chemotherapy in Children With Ewing Sarcoma.
    Ruggiero A; Lanni V; Librizzi A; Maurizi P; Attinà G; Mastrangelo S; Giordano A; Riccardi R
    J Pediatr Hematol Oncol; 2018 May; 40(4):277-284. PubMed ID: 29620679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.
    Völker T; Denecke T; Steffen I; Misch D; Schönberger S; Plotkin M; Ruf J; Furth C; Stöver B; Hautzel H; Henze G; Amthauer H
    J Clin Oncol; 2007 Dec; 25(34):5435-41. PubMed ID: 18048826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis.
    Franzius C; Sciuk J; Brinkschmidt C; Jürgens H; Schober O
    Clin Nucl Med; 2000 Nov; 25(11):874-81. PubMed ID: 11079583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of bone and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer.
    Gayed I; Vu T; Johnson M; Macapinlac H; Podoloff D
    Mol Imaging Biol; 2003; 5(1):26-31. PubMed ID: 14499159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours.
    Györke T; Zajic T; Lange A; Schäfer O; Moser E; Makó E; Brink I
    Nucl Med Commun; 2006 Jan; 27(1):17-24. PubMed ID: 16340719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas.
    Lucas JD; O'Doherty MJ; Wong JC; Bingham JB; McKee PH; Fletcher CD; Smith MA
    J Bone Joint Surg Br; 1998 May; 80(3):441-7. PubMed ID: 9619933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-treatment FDG PET/CT predicts progression-free survival in young patients with small round blue cell tumors: Ewing sarcoma and PNET.
    Sobic Saranovic DP; Nikitovic M; Saponjski J; Grozdic Milojevic I; Paripovic L; Saranovic D; Beatovic S; Artiko VM
    Eur J Radiol; 2020 Aug; 129():109076. PubMed ID: 32446127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG.
    Nakamoto Y; Osman M; Wahl RL
    Clin Nucl Med; 2003 Apr; 28(4):302-7. PubMed ID: 12642709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow examination in patients with Ewing sarcoma/peripheral primitive neuroectodermal tumor without metastasis based on
    Inagaki C; Shimoi T; Sumiyoshi Okuma H; Kawachi A; Sudo K; Shimomura A; Noguchi E; Kodaira M; Yunokawa M; Yonemori K; Shimizu C; Arakawa A; Ogawa C; Yoshida A; Fujiwara Y; Tamura K
    Med Oncol; 2019 May; 36(7):58. PubMed ID: 31104192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of
    Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Accuracy of Computed Tomography and Positron Emission Tomography to Detect Lung and Lymph Node Metastases of Colorectal Cancer.
    Guerrera F; Renaud S; Schaeffer M; Nigra V; Solidoro P; Santelmo N; Filosso PL; Falcoz PE; Ruffini E; Oliaro A; Massard G
    Ann Thorac Surg; 2017 Oct; 104(4):1194-1199. PubMed ID: 28760464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
    Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
    J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.